Article ; Online: Guiding HIV-1 vaccine development with preclinical nonhuman primate research.
Current opinion in HIV and AIDS
2023 Volume 18, Issue 6, Page(s) 315–322
Abstract: Purpose of the review: Nonhuman primates (NHPs) are seen as the closest animal model to humans in terms of anatomy and immune system makeup. Here, we review how preclinical studies in this model system are teaching the field of HIV vaccinology the basic ...
Abstract | Purpose of the review: Nonhuman primates (NHPs) are seen as the closest animal model to humans in terms of anatomy and immune system makeup. Here, we review how preclinical studies in this model system are teaching the field of HIV vaccinology the basic immunology that is needed to induce broadly neutralizing antibodies (bnAbs) with vaccination and elicit protective T cell responses. These lessons are being translated into clinical trials to advance towards protective active vaccination against HIV-1 infection. Recent findings: Preclinical vaccination studies in NHPs have shown that highly engineered HIV-1 immunogens can initiate bnAb precursors providing proof of concept for Phase I clinical trials. Additionally, NHP models of HIV-1 infection are elucidating the pathways for bnAb development while serving as systems to evaluate vaccine protection. Innovative immunization strategies have increased affinity maturation of HIV-1 antibodies in long-lived germinal centers. Preclinical studies in macaques have defined the protective level of neutralizing antibodies and have shown that T cell responses can synergize with antibody-mediated immunity to provide protection in the presence of lower neutralizing antibody titers. Summary: The NHP model provides vaccine regimens and desired antibody and T cell responses that serve as benchmarks for clinical trials, accelerating HIV vaccine design. |
---|---|
MeSH term(s) | Animals ; Humans ; HIV Infections/prevention & control ; HIV-1 ; Broadly Neutralizing Antibodies ; HIV Antibodies ; Antibodies, Neutralizing ; Primates ; Vaccines ; AIDS Vaccines |
Chemical Substances | Broadly Neutralizing Antibodies ; HIV Antibodies ; Antibodies, Neutralizing ; Vaccines ; AIDS Vaccines |
Language | English |
Publishing date | 2023-09-11 |
Publishing country | United States |
Document type | Review ; Journal Article |
ZDB-ID | 2502511-9 |
ISSN | 1746-6318 ; 1746-630X |
ISSN (online) | 1746-6318 |
ISSN | 1746-630X |
DOI | 10.1097/COH.0000000000000819 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6812: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.